Medical Cannabis News

Synonyms: 
mmj
Fri
08
Mar

The NFL may consider changing rules around cannabis use

The National Football League is finally ready to relax its policy on cannabis, according to a report from NBC Sports on Wednesday. Citing an unnamed league source, the network’s Pro Football Talk reports that “the NFL is prepared to make major concessions regarding the substance-abuse policy, especially as it relates to marijuana” in talks for the next collective bargaining agreement with players. Sports analysts expect that the NFL would use the offer of any revision of the substance abuse policy as a bargaining chip in negotiations and expect concessions from the players union in return.

Fri
08
Mar

Is FDA commissioner Scott Gottlieb’s resignation good or bad for marijuana?

The cannabis industry is in a bit of a panic right now over the news that Scott Gottlieb, the commissioner of the U.S. Food and Drug Administration (FDA), is resigning from his post and moving back to Connecticut. Their concern is that his desire to pack-it-up and vacate his position with the Trump Administration will slow down the progress further of sorting out the confusion surrounding hemp-derived cannabidiol (CBD). It was just last month that Gottlieb promised to hold public hearings in April to try and figure out how to properly regulate the substance. Now, no one seems to know whether these meetings will go down as planned or be cast aside.

Fri
08
Mar

THC-A: A better anti-inflammatory and neuro-protectant

While there has been a lot of discussion in the literature, both lay and scientific, about the properties of Cannabidiol (CBD) as an anti-inflammatory and neuroprotectant, there are significant problems with CBD in reality. Tetrahydrocannabinolic acid (THC-A) is another cannabinoid (cannabis-derived medication) that has yet to get the attention it truly deserves. THC-A presents an option that is similar to CBD but better!

Aside from what CBD appears to be able to treat, its main attraction is that it is non-intoxicating (meaning it doesn’t get you high). On the downside, however, the amount of CBD you need to take to get the benefits described in medical studies is 500-1500mg per day, or about $30-80 per day. This is pretty much a show stopper for most patients.

Fri
08
Mar

CO2 v. ethanol extraction: What’s the difference?

Oils, topicals, vapes, pills and edibles: As the market literally blossoms with alternatives to the standard joint and lighter, cannabis extracts are looking pretty sleek.

Colloquially referred to as “hash” or “kief”, depending on the context, producers and consumers alike have been known to employ expensive equipment and don safety gear to suss out cannabis’ raw potential as both a pain-easing healer and a perception-twisting stimulant.

However, precisely how cannabis extract makes its way from the dense, sticky leaves of its native plant to brownies, tinctures and creams hinges on what extraction specialists want out of it.

Thu
07
Mar

NHL Alumni Association partners with Canopy Growth for post-concussion studies

The NHL Alumni Association (NHLAA) announced on the weekend that they are entering a partnership with major Canadian cannabis company Canopy Growth to see how Cannabis could potentially provide medical benefits for former NHL players.

The study will be led by neurosurgeon of NEEKA Healthcare Dr. Amin Kassam. They will specifically examine how certain marijuana compounds can treat illnesses associated with concussions.

“As we continue to break new ground, push for increasing understanding as a medicine, we feel it is necessary for ourselves to step up and advance research in this space,” Chief Medical Officer of Canopy Growth Dr. Mark Ware said at an event in Toronto.

Thu
07
Mar

Helix TCS system allows North Dakota to track and trace the state’s entire medical cannabis supply chain

Helix TCS, Inc., through its cannabis seed-to-sale tracking and point-of-sale subsidiary, BioTrackTHC, has officially deployed North Dakota’s government medical cannabis traceability system.

The system “will track and trace the state’s entire medical cannabis supply chain for compliance and regulatory oversight,” notes a statement from Helix TCS, a provider of ancillary services for the legal cannabis industry that reports having met all go-live deadlines for its government-contracted traceability solutions.

Thu
07
Mar

Georgia House passes Bill to allow manufacture, sale of medical cannabis oil

A bill that would allow licensed companies to manufacture and sell medicinal cannabis oil was passed by the Georgia House of Representatives on Tuesday and is now headed to the state Senate for consideration. Under the bill, HB 324, a regulated system for growing, processing, and distributing cannabis oil would be established. Georgia’s medical marijuana program only permits the use of cannabis oil with no more than 5 percent THC by registered patients with one or more of 16 qualifying serious medical conditions.

Thu
07
Mar

Canada's medical cannabis programs are poorly regulated, UN Agency says

The United Nations’ International Narcotics Control Board (INCB) warned governments around the globe that countries who have legalized the use of medical cannabis must ensure that those programs are used exclusively for their intended use, and not to “de facto legalize” cannabis for recreational use.

The Vienna-based INCB is the “independent and quasi-judicial monitoring body for the implementation of the United Nations international drug control conventions,” and is responsible for some regulations on psychotropics and narcotics and for monitoring how narcotics-related restrictions are enforced.

Thu
07
Mar

Committee advances medical marijuana bill in Kentucky

A bill to legalize medical marijuana in Kentucky won initial committee approval Wednesday night after lawmakers heard emotional testimony from people battling chronic pain and debilitating medical conditions.

The bill, which would make marijuana legal in the bluegrass state for medical purposes only, cleared the House Judiciary Committee on a 16-1 vote after a two-hour hearing.Advertisement

With only a few days left in this year's legislative session, the measure faces tough odds of becoming law. The bill heads to the Republican-led House next.

"It's not too late," said Rep. Jason Nemes, a leading sponsor of the bill. "Where there's a will there's a way. We have enough days. We're going to need a good push. It's not probable."

Pages

Subscribe to RSS - Medical Cannabis News